Terms: = Germ cell tumor AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Prognosis
23 results:
1. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
2. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
[TBL] [Abstract] [Full Text] [Related]
3. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma cells.
Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of Small-Molecule Inhibitors of the hsp90-Calcineurin-NFAT Pathway against Glioblastoma.
Liu Z; Li H; He L; Xiang Y; Tian C; Li C; Tan P; Jing J; Tian Y; Du L; Huang Y; Han L; Li M; Zhou Y
Cell Chem Biol; 2019 Mar; 26(3):352-365.e7. PubMed ID: 30639261
[TBL] [Abstract] [Full Text] [Related]
5. Low co-expression of epidermal growth factor receptor and its chaperone heat shock protein 90 is associated with worse prognosis in primary glioblastoma, IDH-wild-type.
Sartori E; Langer R; Vassella E; Hewer E; Schucht P; Zlobec I; Berezowska S
Oncol Rep; 2017 Oct; 38(4):2394-2400. PubMed ID: 28765916
[TBL] [Abstract] [Full Text] [Related]
6. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
[TBL] [Abstract] [Full Text] [Related]
7. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2.
Liang J; Cao R; Wang X; Zhang Y; Wang P; Gao H; Li C; Yang F; Zeng R; Wei P; Li D; Li W; Yang W
Cell Res; 2017 Mar; 27(3):329-351. PubMed ID: 28035139
[TBL] [Abstract] [Full Text] [Related]
8. Expression of heat shock proteins in brain tumors.
Alexiou GA; Karamoutsios A; Lallas G; Ragos V; Goussia A; Kyritsis AP; Voulgaris S; Vartholomatos G
Turk Neurosurg; 2014; 24(5):745-9. PubMed ID: 25269047
[TBL] [Abstract] [Full Text] [Related]
9. Expression of TRAP1 predicts poor survival of malignant glioma patients.
Li S; Lv Q; Sun H; Xue Y; Wang P; Liu L; Li Z; Li Z; Tian X; Liu YH
J Mol Neurosci; 2015 Jan; 55(1):62-68. PubMed ID: 25189320
[TBL] [Abstract] [Full Text] [Related]
10. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, hsp90 and histone deacetylases.
Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA
BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474
[TBL] [Abstract] [Full Text] [Related]
11. Potent antitumor activity of the novel hsp90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.
Zitzmann K; Ailer G; Vlotides G; Spoettl G; Maurer J; Göke B; Beuschlein F; Auernhammer CJ
Int J Oncol; 2013 Dec; 43(6):1824-32. PubMed ID: 24100469
[TBL] [Abstract] [Full Text] [Related]
12. Expression of heat shock proteins in medulloblastoma.
Alexiou GA; Vartholomatos G; Stefanaki K; Patereli A; Dova L; Karamoutsios A; Lallas G; Sfakianos G; Moschovi M; Prodromou N
J Neurosurg Pediatr; 2013 Nov; 12(5):452-7. PubMed ID: 23992239
[TBL] [Abstract] [Full Text] [Related]
13. Expression and diagnostic relevance of heat shock protein 90 and signal transducer and activator of transcription 3 in malignant pheochromocytoma.
Xu Y; Qi Y; Rui W; Zhu Y; Zhang C; Zhao J; Wei Q; Wu Y; Shen Z; Ning G
J Clin Pathol; 2013 Apr; 66(4):286-90. PubMed ID: 23322822
[TBL] [Abstract] [Full Text] [Related]
14. Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.
Kim YW; Kwon C; Liu JL; Kim SH; Kim S
PLoS One; 2012; 7(8):e40960. PubMed ID: 22952576
[TBL] [Abstract] [Full Text] [Related]
15. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone hsp90.
Trisciuoglio D; Gabellini C; Desideri M; Ziparo E; Zupi G; Del Bufalo D
PLoS One; 2010 Jul; 5(7):e11772. PubMed ID: 20668552
[TBL] [Abstract] [Full Text] [Related]
16. The novel hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme.
Zhu H; Woolfenden S; Bronson RT; Jaffer ZM; Barluenga S; Winssinger N; Rubenstein AE; Chen R; Charest A
Mol Cancer Ther; 2010 Sep; 9(9):2618-26. PubMed ID: 20643786
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistic evaluation of the novel hsp90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma.
Gaspar N; Sharp SY; Eccles SA; Gowan S; Popov S; Jones C; Pearson A; Vassal G; Workman P
Mol Cancer Ther; 2010 May; 9(5):1219-33. PubMed ID: 20457619
[TBL] [Abstract] [Full Text] [Related]
18. Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells.
Gaspar N; Sharp SY; Pacey S; Jones C; Walton M; Vassal G; Eccles S; Pearson A; Workman P
Cancer Res; 2009 Mar; 69(5):1966-75. PubMed ID: 19244114
[TBL] [Abstract] [Full Text] [Related]
19. Immune expression and inhibition of heat shock protein 90 in uveal melanoma.
Faingold D; Marshall JC; Antecka E; Di Cesare S; Odashiro AN; Bakalian S; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(3):847-55. PubMed ID: 18245548
[TBL] [Abstract] [Full Text] [Related]
20. Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway.
Li Z; Thiele CJ
Expert Opin Ther Targets; 2007 Dec; 11(12):1611-21. PubMed ID: 18020981
[TBL] [Abstract] [Full Text] [Related]
[Next]
